TOP STORIES
Valeant Pharmaceuticals’ Michael Pearson is back from medical leave, and that’s triggered a host of other developments. The company will also withdraw its financial forecast and delay fourth-quarter results. Pearson will also give up his title as chairman of the company. – Bloomberg
Looking for more MedCity News HIMSS16 coverage? This entire week we’ll have a special edition of our daily newsletter sent out at 10 a.m. Eastern containing all of our HIMSS coverage from the past 24 hours. Sign up for our daily newsletter and you’ll also receive our HIMSS coverage in your inbox.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
Succession plans are underway at GlaxoSmithKline for Andrew Witty; don’t expect an announcement before 2017. – Reuters
Orphan-drug companies are cheaper so Sanofi is back into buying rare disease treatments “up to the size of Genzyme.” – Financial Times
Mixed results for two studies of Genentech’s Lebrikizumab, which looks to treat asthma and other afflictions. – FierceBiotech
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
BioInvent International shows progress on its solid-cancer tumor treatment; it’s getting a more than $2 million milestone payment from Daiichi Sankyo for moving its treatment into a Phase I trial in Europe. – Business Wire
PAYERS-PROVIDERS
It turns out many of those doctor tweets may just be, at worst, veiled ads for drugmakers or, at best, too short to detail conflicts of interest. – STAT and STAT
Here’s why climate information may be key weapon in fight against Zika spread. – Reuters
TECHNOLOGY
Virtual reality in medicine: Addicts in a University of Houston study will wear virtual reality headsets and enter a “heroin cave” to fight addictions.- Reuters
HealthMine has built an advisory board that include former House Major Leader Dick Gephardt for former Colorado Gov. Bill Owens. All men. – PRNewswire
POLITICS
The author of Bernie Sanders’ health plan defends his numbers, while a critic tears into Sanders’ single-payer approach and shows why he thinks it will cost much more than the campaign lets on. A great deep dive on both fronts. – American Prospect
Well look at that: some real clues at what a Donald Trump health plan would look like. – The Hill
Why Congressional action on opioid abuse my go kaput. – The Hill
A LITTLE BIT EXTRA
Get your Oscar fix – including Leo’s big win and Chris Rock’s opening monologue (he raised more than $55,000 for a local Girl Scout troop!). – LA Times
